Gene · 5339
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative Phosphoproteomics Analysis Uncovers PAK2- and CDK1-Mediated Malignant Signaling Pathways in Clear Cell Renal Cell Carcinoma. | Mol Cell Proteomics | 2022 | 36152754 | PubTator, text mining | PubMed |
| Significance of Capping Agents of Colloidal Nanoparticles from the Perspective of Drug and Gene Delivery, Bioimaging, and Biosensing: An Insight. | Int J Mol Sci | 2022 | 36142435 | PubTator, text mining | PubMed |
| Links of Cytoskeletal Integrity with Disease and Aging. | Cells | 2022 | 36139471 | PubTator, text mining | PubMed |
| Landscape of exitrons in gastric cancer. | EBioMedicine | 2022 | 36137412 | PubTator, text mining | PubMed |
| Depression and bipolar disorder subtypes differ in their genetic correlations with biological rhythms. | Sci Rep | 2022 | 36131119 | PubTator, text mining | PubMed |
| The genetic architecture of phenotypic diversity in the Betta fish (Betta splendens). | Sci Adv | 2022 | 36129976 | PubTator, text mining | PubMed |
| CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. | Cell Death Dis | 2022 | 36123327 | PubTator, text mining | PubMed |
| The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? | J Exp Clin Cancer Res | 2022 | 36114508 | PubTator, text mining | PubMed |
| Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer. | Chin Med J (Engl) | 2022 | 36113844 | PubTator, text mining | PubMed |
| Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study. | Lancet Healthy Longev | 2022 | 36102775 | PubTator, text mining | PubMed |
| Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow-up. | Skin Health Dis | 2022 | 36092265 | PubTator, text mining | PubMed |
| COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa. | Front Med (Lausanne) | 2022 | 36091706 | PubTator, text mining | PubMed |
| Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas. | Oncogenesis | 2022 | 36085291 | PubTator, text mining | PubMed |
| Downstream Effects of Mutations in SOD1 and TARDBP Converge on Gene Expression Impairment in Patient-Derived Motor Neurons. | Int J Mol Sci | 2022 | 36077049 | PubTator, text mining | PubMed |
| Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients. | Int J Mol Sci | 2022 | 36077033 | PubTator, text mining | PubMed |
| Differential venom gland gene expression analysis of juvenile and adult scorpions Androctonus crassicauda. | BMC Genomics | 2022 | 36076177 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part I. | Rom J Morphol Embryol | 2022 | 36074664 | PubTator, text mining | PubMed |
| Laminin 332-functionalized coating to regulate the behavior of keratinocytes and gingival mesenchymal stem cells to enhance implant soft tissue sealing. | Regen Biomater | 2022 | 36072266 | PubTator, text mining | PubMed |
| Suppression of trinucleotide repeat expansion in spermatogenic cells in Huntington's disease. | J Assist Reprod Genet | 2022 | 36066723 | PubTator, text mining | PubMed |
| Validation of the Individualized Neuromuscular Quality of Life Questionnaire in Korean Patients With Genetic Neuromuscular Diseases. | J Clin Neurol | 2022 | 36062768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5339/papers?page=25